In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research.
Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fellow at Mitsubishi Tanabe Pharma, and Chief Medical Officer at Zynerba and BioVie. His work spans the entire R&D lifecycle—from early innovation to global approvals—and includes major FDA registrations such as Risperdal Consta®, Invega®, Invega Sustenna®, and Radicava®.
Currently serving as Executive Vice President, Head of R&D, and Chief Medical Officer at BioVie Inc., Dr. Palumbo also leads a $13 million U.S. Department of Defense study on Long COVID. With more than 3,000 scientific citations and over 10 issued patents, he brings a unique blend of translational science and executive leadership focused on advancing patient care through innovation.
